UC2288 is a novel, cell-permeable, and orally active p21 attenuator, decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability.
[1] Wettersten HI, et al. Cancer Biol Ther. 2013 Mar;14(3):278-85.
















